Ara
Toplam kayıt 6, listelenen: 1-6
Effects of obesity on upper extremity range of motion in children
(İstanbul Bilim Üniversitesi, Tıp Fakültesi, 2016)
Objectives: This study aims to assess the effects of obesity on upper extremity range of motion in children.
Materials and methods: This cross-sectional study covers 153 participants (85 boys, 68 girls; mean age 8.3±3.6 ...
Çocuklarda inek sütü alerjisine yaklaşım
(Approach to cow’s milk allergy in childhoodİstanbul Bilim Üniversitesi, Tıp Fakültesi, 2015-08)
Tüm dünyada olduğu gibi ülkemizde de besin alerjilerinin sıklığı giderek artmaktadır. Çocuklarda en sık alerjiye neden olan besinler inek sütü ve yumurtadır. İnek sütü alerjisi; IgE aracılı, IgE aracılı olmayan (hücresel) ...
Plasma levels of matrix metalloproteinase-9 in children with chronic spontaneous urticaria
(The Korean Academy of Asthma Allergy and Clinical Immunology, 2016)
Purpose: Chronic spontaneous urticaria (CSU) is a disease that is primarily seen in adults and is comparatively rare in children. Consequently, only a few studies have focused on the pathogenesis of the disease in children. ...
Fine-needle aspiration biopsy in the diagnosis and follow-up of thyroid nodules in childhood.
(Galenos Yayınevi, 2010)
Objective: To assess the role of fine-needle aspiration biopsy (FNAB) in the management of pediatric thyroid nodules.
Methods: Results of 30 FNABs performed in our clinic were retrospectively reviewed. Clinical and surgical ...
Renal outcome with eculizumab in two diarrhea-associated hemolyticeuremic syndrome cases with severe neurologic involvement
(Elsevier, 2014)
The kidney and brain are the two target organs in patients with Shiga toxin-producing Escherichia coli-associated hemolytic–uremic syndrome (STEC-HUS). Activation of the alternative complement pathway occurs in patients ...
Growth of children with type 1 diabetes mellitus.
(Galenos Yayınevi, 2010)
Objective: To retrospectively evaluate the effect of type 1 diabetes on growth.
Methods: Patients with Type 1 diabetes mellitus (T1DM) followed for at least one year after diagnosis, and without coexisting disorder that ...